Cure8 research brief
The survey highlights inconsistent perioperative and medication-management practices around paediatric IBD surgery across international centres, which could affect outcomes and points to opportunities for benchmarking and consensus to improve care.
Pediatric patients with IBD and their caregivers, pediatric surgeons, pediatric gastroenterologists, hospital administrators, and researchers planning multicentre studies or guidelines.
The study used a 28-item centre-level questionnaire completed by predominantly university/teaching hospitals and paediatric surgeons, reporting practices in 2018, 2022, and 2024.
Key findings include low median annual surgical volumes for paediatric Crohn's disease and ileal pouch procedures, only half of centres using enhanced recovery protocols, and heterogeneous approaches to withholding corticosteroids and anti-TNF agents before surgery.
Care implications These results do not prescribe specific care changes but provide a baseline for benchmarking, consensus development, and collaborative research to standardise perioperative optimisation and integration of medical and surgical care for children with IBD.
This is a cross-sectional, centre-level survey (abstract-level summary). It describes reported practices rather than patient-level outcomes; it provides a baseline for future consensus and prospective research rather than definitive evidence on best practices.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The review links specific therapies and surgical options to outcomes that matter to people with IBD — mucosal healing, lower hospitalizations, and reduced need for surgery — and highlights that combining medical and...
Pediatric-onset IBD can behave differently than adult-onset disease. Comparing conventional versus biologic approaches in children may help clarify relative effectiveness, safety, and impacts on growth and steroid...
People with IBD and clinicians often face decisions about whether to stop biologics or small molecules before abdominal surgery.
